AusCann Group Holdings Ltd (ACNNF) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The company is headquartered in West Perth, WA, Australia. The current CEO is Christopher Mews B. Bus,.
ACNNF has IPO date of 2017-02-10, 27 full-time employees, listed on the Other OTC, a market capitalization of $1.67M.
AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.
